INTERNATIONAL PATENT: GEMVAX & KAEL CO.,LTD., 주식회사 젬백스앤카엘 FILES APPLICATION FOR "COMPOSITION COMPRISING GV1001 PEPTIDE FOR REDUCING CD47 EXPRESSION IN CANCER CELLS AND INCREASING PHAGOCYTOSIS BY MACROPHAGES AND USE THEREOF"

GENEVA, April 7 -- GEMVAX & KAEL CO.,LTD. ((Tapnip-dong) 58, Techno 11-ro, Yuseong-gu, Daejeon 34036), 주식회사 젬백스앤카엘 (대전광역시유성구테크노11로 58 (탑립동)) filed a patent application (PCT/KR2025/015493) for "COMPOSITION COMPRISING GV1001 PEPTIDE FOR REDUCING CD47 EXPRESSION IN CANCER CELLS AND INCREASING PHAGOCYTOSIS BY MACROPHAGES, AND USE THEREOF" on Sep 30, 2025. With publication no. WO/2026/071839, the details related to the patent application was published on Apr 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, ...